Search

Search Constraints

You searched for: Author/Creator Thurlings, Rogier M

Search Results

1. A1.73 Relationship between expression of synovial B cell survival factors and clinical response to rituximab treatment in rheumatoid arthritis. (31st January 2014)

2. Biomarker profiles of endothelial activation and dysfunction in rare systemic autoimmune diseases: implications for cardiovascular risk. (18th August 2020)

3. Effect of rituximab treatment on T and B cell subsets in lymph node biopsies of patients with rheumatoid arthritis. (10th January 2019)

4. MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Issue 3 (2nd December 2013)

5. Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire. Issue 10 (19th June 2019)

6. Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire. Issue 10 (October 2019)

7. Predictive value of serum calprotectin (S100A8/A9) for clinical response after starting or tapering anti-TNF treatment in patients with rheumatoid arthritis. Issue 1 (9th April 2018)

8. Presence of lymphocyte aggregates in the synovium of patients with early arthritis in relationship to diagnosis and outcome: is it a constant feature over time?. Issue 4 (20th December 2010)

9. Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sjögren's syndrome. Issue 5 (10th February 2022)